ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,188 | +4.9% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $151,725 | +41.5% | 1,700 | +70.0% | 0.00% | +100.0% |
| Q1 2023 | $107,220 | +75.6% | 1,000 | +100.0% | 0.00% | 0.0% |
| Q4 2022 | $61,065 | -98.6% | 500 | -98.8% | 0.00% | -97.8% |
| Q3 2022 | $4,254,000 | +12.5% | 41,200 | +1.2% | 0.05% | +21.1% |
| Q2 2022 | $3,783,000 | -20.8% | 40,700 | 0.0% | 0.04% | -19.1% |
| Q1 2022 | $4,776,000 | – | 40,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |